Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

How might diabetes devices improve in the future? Kerri Morrone Sparling offers us her wish list.
Earlier this month, an initial regulatory assessment committee recommended the novel type 2 diabetes therapy dapagliflozin (Forxiga) for approval in Europe. A final...
Think of how many people need to wear glasses just to see! Rather than considering them as a necessary evil, some folks celebrate them by investing in stylish (sometimes...
International Society for Pediatric and Adolescent Diabetes (ISPAD)
The Wonders of Byetta: One Man’s Weight-Loss Journey
Alisa’s ally, Alli
On June 12, Team Type 1 began the 3,043-mile Race Across America to show the world that “diabetics can do anything and everything that non-diabetics can do,” in the...
One of our writers takes the WaveSense Jazz meter out for a spin.
A DPP-What? A closer look at a new kind of drug, Januvia.
On April 9, the FDA announced that it had extended the decision date for Vivus’ obesity medication Qnexa by three months to July 17. The agency postponed its approval...
From conferences to Avandia to burritos… What a trip!
Life for a Child is a sister program to Insulin for Life. It was established in 2001 as a sustainable sponsorship program where people can help children in developing...
Pumpers, be alerted! Last week, Animas launched the new Animas 2020 insulin pump, now the smallest traditional pump on the market. Some of the 2020's features include a...
In Search of Reimbursement: A CGM Odyssey
We review an excellent book by blogger extraordinare Amy Tenderich
To Seattle, Barcelona, and back with new information.
The Changing Diabetes Bus rolled onto the scene in June, for the US segment of its tour around the world. After a trek through Europe, Africa, Australia, Asia, and...
Talking with two diabetes titans, Dr. Irl Hirsch, endocrinologist extraordinaire, and Arnold Donald, striking new head of the JDRF.
We are encouraged to report that the FDA has approved Levemir for use in pregnant women with type 1, type 2, or gestational diabetes. Levemir is a long acting, or “basal...
Olive oil, wine and the ‘French Paradox.’

Pages